NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 99 filers reported holding NEWLINK GENETICS CORP in Q1 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $873,000 | -9.4% | 24,001 | -10.8% | 0.00% | 0.0% |
| Q3 2015 | $964,000 | -32.4% | 26,892 | -16.6% | 0.00% | -33.3% |
| Q2 2015 | $1,427,000 | +50.7% | 32,241 | +86.3% | 0.00% | +50.0% |
| Q1 2015 | $947,000 | -7.0% | 17,309 | -32.4% | 0.00% | 0.0% |
| Q4 2014 | $1,018,000 | +62.1% | 25,609 | -12.6% | 0.00% | 0.0% |
| Q3 2014 | $628,000 | -41.3% | 29,309 | -27.3% | 0.00% | -33.3% |
| Q2 2014 | $1,070,000 | -3.7% | 40,309 | +3.1% | 0.00% | 0.0% |
| Q1 2014 | $1,111,000 | – | 39,109 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |